Nuvectra Corp. priced a follow-on public offering of 2,825,000 common shares at $8 apiece.
The Plano, Texas-based medical device company granted the underwriters an option to buy up to 423,750 additional shares.
The offering is expected to close Feb. 5.
Piper Jaffray is acting as sole book-running manager, while JMP Securities and SunTrust Robinson Humphrey are acting as co-managers for the offering.
